scholarly journals Seroprevalence of Chlamydophila psittaci among employees of two German duck farms

2017 ◽  
Vol 7 (4) ◽  
pp. 267-273 ◽  
Author(s):  
Raimond Lugert ◽  
Uwe Groß ◽  
Wycliffe O. Masanta ◽  
Gunter Linsel ◽  
Astrid Heutelbeck ◽  
...  
Pneumologie ◽  
2004 ◽  
Vol 58 (11) ◽  
Author(s):  
D Theegarten ◽  
O Anhenn ◽  
H Hotzel ◽  
G Rohde ◽  
T Bexten ◽  
...  

2013 ◽  
Vol 68 (7) ◽  
pp. 57-60
Author(s):  
O. A. Sharavii ◽  
S. V. Smirnova

 Aim. The study of the prevalence and clinical peculiarities of Mycoplasmosis and Chlamydiosis in patients with different pathogenic forms of bronchial asthma (BA) taking into account ethnicity of a patient. Subjects and Methods. The research covered 239 subjects – both the Europeoids and the Mongoloids in the city of Krasnoyarsk and the town of Kyzyl, all of them being BA patients of different stages, including acute stage and practically healthy. We had determined antigens Mycoplasma pneumoniae, Mycoplasma hominis, Chlamydophila pneumoniae, Chlamydophila psittaci and Chlamydia trachomatis in smears of mucosa of pharynx and antibodies to these antigens in peripheral blood serum. Results.  We found high frequency of Mycoplasmosis and Chlamydiosis in the inhabitants of Eastern Siberia, BA patients with different pathogenic forms as compared to control group. We had determined ethnic peculiarities of specific immune response: IgM to М. pneumoniae was revealed in the Europoids more frequently than in the Mongoloids, but IgM to С. pneumoniae and to C. trachomatis, C. trachomatis antigens had been revealed more often in the Mongoloids than in the Europoids. We accepted as clinical equivalents of Mycoplasmosis and Chlamydiosis diagnostics the following signs: temperature around 37C (subfebrile temperature), non-intensive but stable coughing with scanty mucous and muco-purulent sputum, dyspnea of mixed character. Conclusions. Mycoplasma and Chlamydia are meaningful etiologic factors of bronchial asthma. We have found the peculiarities of immune response depending on ethnicity of a patient (ethnic belonging). Clinical markers of Mycoplasmosis and Chlamydiosis should be taken into account in bronchial asthma in order to provide diagnostics timely as well as eradication of infection agents. Because of insufficient knowledge of problem of bronchial asthma related to contamination with Мycoplasma and Chlamydia we put the goal to study the frequency of Mycoplasmosis and Chlamydiosis occurrence in bronchial asthma patients and determine the characteristics clinical course of diseases. We defined antigens Мycoplasma pneumoniae, Мycoplasma hominis, Chlamydophila pneumoniaе, Chlamydophila psittaci, Chlamydia trachomatis in smears of oropharynx mucosa and antibodies to them in blood serum. 


2003 ◽  
Author(s):  
Charles Thomas Parker ◽  
Nicole Danielle Osier ◽  
George M Garrity

2014 ◽  
Vol 42 (3) ◽  
pp. 67-76
Author(s):  
Hegazy AM ◽  
El-Sisi MA ◽  
Hadia AA ◽  
Hala MNT

2011 ◽  
Vol 41 (5) ◽  
pp. 841-847 ◽  
Author(s):  
Laila Maftoum Proença ◽  
José Jurandir Fagliari ◽  
Tânia de Freitas Raso

A clamidiose ou ornitose é uma doença infecciosa, causada pela bactéria Chlamydophila psittaci, que acomete aves e mamíferos. Trata-se de uma das principais zoonoses de origem aviária. A transmissão ocorre principalmente por inalação de secreções contaminadas. Os sinais clínicos mais comuns incluem alterações no sistema gastrointestinal, respiratório e ocular, porém é possível encontrar aves infectadas sem sinais aparentes, dificultando a identificação da doença. O diagnóstico definitivo em aves vivas pode ser difícil, devido às características da infecção pela bactéria. Há duas principais abordagens para o diagnóstico, a primeira envolve a detecção direta da bactéria e a segunda implica a detecção de anticorpos anti-Chlamydophila sp. O tratamento é longo e envolve o uso de tetraciclinas, quinolonas ou macrolídeos, durante 21-45 dias, dependendo da espécie e do fármaco de escolha. Atualmente, o Brasil não dispõe de medidas padronizadas que visam a guiar o clínico na identificação, manejo e tratamento para a doença. Tais medidas tornam-se necessárias, bem como a pesquisa de novos métodos diagnósticos e auxiliares para a doença.


2009 ◽  
Vol 55 (6) ◽  
pp. 575-581 ◽  
Author(s):  
Daniela Zweifel ◽  
Richard Hoop ◽  
Konrad Sachse ◽  
Andreas Pospischil ◽  
Nicole Borel

2013 ◽  
Vol 112 (7) ◽  
pp. 430-433 ◽  
Author(s):  
Yu-Jen Cheng ◽  
Kun-Yen Lin ◽  
Chun-Chen Chen ◽  
Yen-Lin Huang ◽  
Chun-Eng Liu ◽  
...  

Glycobiology ◽  
2009 ◽  
Vol 20 (4) ◽  
pp. 461-472 ◽  
Author(s):  
S. Gerstenbruch ◽  
C. L Brooks ◽  
P. Kosma ◽  
L. Brade ◽  
C R. MacKenzie ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document